Upon confirming the immune response to CD47−/− cancer cells, we next sought to determine whether γ-irradiate, non-replicating CD47−/− cancer cells can be used as a vaccine to suppress tumor growth and reduce tumor progression. Here, CD47 is linked to neoplasm.